QuantaMatrix Inc.
QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early dia… Read more
Market Cap & Net Worth: QuantaMatrix Inc. (317690)
QuantaMatrix Inc. (KQ:317690) has a market capitalization of $49.40 Million (₩72.34 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22067 globally and #1096 in its home market, demonstrating a 1.79% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying QuantaMatrix Inc.'s stock price ₩3695.00 by its total outstanding shares 19577021 (19.58 Million).
QuantaMatrix Inc. Market Cap History: 2020 to 2026
QuantaMatrix Inc.'s market capitalization history from 2020 to 2026. Data shows change from $299.50 Million to $49.40 Million (-29.94% CAGR).
Index Memberships
QuantaMatrix Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #518 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #518 of 1384 |
Weight: QuantaMatrix Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
QuantaMatrix Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how QuantaMatrix Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
QuantaMatrix Inc.'s market cap is 0.03 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $299.50 Million | $1.69 Billion | -$14.66 Billion | 0.18x | N/A |
| 2021 | $144.40 Million | $549.77 Million | -$18.12 Billion | 0.26x | N/A |
| 2022 | $61.77 Million | $1.29 Billion | -$19.24 Billion | 0.05x | N/A |
| 2023 | $62.31 Million | $3.12 Billion | -$21.56 Billion | 0.02x | N/A |
| 2024 | $86.37 Million | $2.50 Billion | -$20.17 Billion | 0.03x | N/A |
Competitor Companies of 317690 by Market Capitalization
Companies near QuantaMatrix Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to QuantaMatrix Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
QuantaMatrix Inc. Historical Marketcap From 2020 to 2026
Between 2020 and today, QuantaMatrix Inc.'s market cap moved from $299.50 Million to $ 49.40 Million, with a yearly change of -29.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩49.40 Million | -22.86% |
| 2025 | ₩64.04 Million | -25.85% |
| 2024 | ₩86.37 Million | +38.63% |
| 2023 | ₩62.31 Million | +0.87% |
| 2022 | ₩61.77 Million | -57.22% |
| 2021 | ₩144.40 Million | -51.79% |
| 2020 | ₩299.50 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of QuantaMatrix Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $49.40 Million USD |
| MoneyControl | $49.40 Million USD |
| MarketWatch | $49.40 Million USD |
| marketcap.company | $49.40 Million USD |
| Reuters | $49.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.